Patients are often asked to sign a consent form right before banking, and many sign without fully understanding what they are agreeing to. This guide explains what a banking consent form should and should not say, the elements a legitimate form contains, the state disclosure laws a patient may encounter, and the red flags that signal a problem. Reading this before signing helps a patient consent with genuine understanding.
TLDR: A legitimate adipose banking consent form describes the banking procedure as preservation, not therapy, discloses that no adipose-derived product is FDA-approved for disease treatment, and makes no promise of future access or benefit. A sound form covers the procedure, FDA status, the absence of guarantees, procedural risks, and costs. Some states, including Florida and Utah, have disclosure laws governing non-FDA-approved stem cell therapy that reflect the broader disclosure environment. Banking adipose tissue preserves a person’s own tissue under 21 CFR Part 1271; it is not a treatment, and it does not guarantee eligibility, access, or clinical benefit.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease or condition. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
A consent form is a legal document, so understanding it matters. The sections below explain what to look for, drawing on the physician-facing overview of informed consent requirements for the regulatory mechanics.
What a Banking Consent Form Should and Should Not Say
A banking consent form should describe what a patient is actually agreeing to: the collection of adipose tissue and its preservation through processing and storage. It should be explicit that banking is preservation, not a treatment, and that no adipose-derived product is FDA-approved for disease treatment. It should also state plainly that banking does not guarantee future access, eligibility, or clinical benefit.
Equally important is what a consent form should not say. It should not promise that the tissue will treat a condition, it should not guarantee access to any future therapy or clinical trial, and it should not imply outcomes that are not established. A form that makes such promises is misrepresenting what banking is, and that is a reason for serious caution. The overview of adipose tissue banking describes what the service actually involves.
The Five Elements That Should Be in Any Legitimate Consent Form
A sound banking consent form generally contains five elements. First, a clear description of the banking procedure, including the harvest, processing, and storage, framed as preservation. Second, an explicit statement that banking is not a treatment and that no adipose-derived product is FDA-approved for disease treatment. Third, a clear statement that banking guarantees no future access, eligibility, or clinical benefit.
Fourth, a disclosure of the risks of the harvest procedure, so a patient understands what the collection involves. Fifth, clear information about costs, including initial and ongoing storage costs, and what happens to the tissue, including the conditions under which it could be retrieved. A patient should be able to find each of these elements in the form, and their absence is a warning sign. The overview of choosing a provider covers what a transparent service looks like.
State-Specific Requirements You May Encounter
Some states have enacted laws governing disclosure and consent for non-FDA-approved stem cell therapy, and a patient may encounter references to them in this space. It is important to understand what these laws actually govern, because they primarily address administering non-FDA-approved therapy rather than tissue banking specifically.
In Florida, Florida Statutes Section 458.3245, enacted through SB 1768 and effective July 1, 2025, governs physicians who administer certain non-FDA-approved stem cell therapies and includes disclosure and informed-consent obligations. In Utah, Utah Code Section 58-1-512, titled Stem cell disclosure and enacted in 2024, requires a health care provider performing a stem cell therapy not approved by the FDA to give the patient a specified written notice and obtain signed consent before the therapy. These are therapy-disclosure laws, not banking-consent statutes, but they reflect a broader environment in which honest disclosure of FDA status is expected. Because banking is preservation rather than the therapy these laws govern, a banking consent should still clearly disclose that banking is not a treatment and that no adipose-derived product is FDA-approved for disease treatment.
Red Flags in a Consent Form
The clearest warning signs often appear in the language of the form itself. A form that promises treatment, outcomes, or trial access is not describing banking accurately, and a form that omits FDA-status disclosure or procedural risks is incomplete. The overview of how to spot fake stem cell clinics covers related warning signs in the therapy context.
The table below summarizes red flags in a consent form and what a legitimate form does instead.
| Red flag in a consent form | What a legitimate form does instead |
|---|---|
| States or implies the tissue is a treatment | Describes banking as preservation, not therapy |
| Promises specific outcomes or miracle results | Makes no promise of any clinical outcome |
| Claims stored tissue secures future trial access | States banking does not create trial eligibility |
| Claims the service is “FDA approved” | Discloses that no adipose-derived product is FDA-approved for disease treatment |
| Omits the risks of the harvest procedure | Discloses procedural risks clearly |
| Pressures you to sign immediately | Gives you time to review and ask questions |
| Is vague about costs or what happens to your tissue | States costs and retrieval conditions clearly |
Your Right to Ask Questions Before You Sign
A patient always has the right to understand a document before signing it. A patient can take time to read the consent form, ask the provider to explain anything unclear, and request clarification on the procedure, the FDA status, the absence of guarantees, the risks, and the costs. A legitimate provider welcomes these questions and answers them clearly.
A patient may also wish to consult their own physician, or in some cases an attorney, before signing a legal document, particularly for a long-term commitment. There is no reason to feel rushed, because banking is elective and a patient is entitled to consent with full understanding. A provider that pressures a patient to sign quickly is showing a warning sign, not offering a benefit.
Frequently Asked Questions
What is the most important thing a banking consent form should say?
That banking is preservation, not a treatment, and that no adipose-derived product is FDA-approved for disease treatment. A legitimate form is explicit that banking guarantees no future access, eligibility, or clinical benefit.
Do Florida and Utah have banking consent laws?
Florida Statutes Section 458.3245 and Utah Code Section 58-1-512 are disclosure laws governing non-FDA-approved stem cell therapy, not banking specifically. They primarily address administering unapproved therapy, but they reflect an environment in which honest disclosure of FDA status is expected.
Can I take the consent form home before signing?
Yes. A patient has the right to read and understand a consent form before signing, to ask questions, and to consult a physician or attorney. A legitimate provider gives a patient time and does not pressure a quick signature.
What consent-form language should make me cautious?
Language promising treatment, specific outcomes, or assured trial access, claims that the service is FDA approved, or a form that omits FDA-status disclosure or procedural risks. These are signs the form is not describing banking accurately.
How is adipose tissue banking regulated?
Banked adipose tissue is handled under 21 CFR Part 1271, the federal framework governing screening, processing, and storage of human cells and tissues.
Key Takeaways
For patients about to sign, understanding the consent form is part of consenting genuinely. A legitimate adipose banking consent form describes banking as preservation rather than therapy, discloses that no adipose-derived product is FDA-approved for disease treatment, makes no promise of future access or benefit, discloses procedural risks, and states costs and retrieval conditions clearly. Florida Statutes Section 458.3245 and Utah Code Section 58-1-512 are disclosure laws for non-FDA-approved therapy rather than banking-consent statutes, but they reflect an environment of expected honesty about FDA status. A patient always has the right to take time, ask questions, and consult a physician or attorney before signing. Above all, banking adipose tissue is a preservation service for potential future use; it is not a treatment, and it does not guarantee eligibility, access, or clinical benefit.
Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, and Nevada governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Patients preparing to review a consent form can learn what a transparent service looks like and contact the team with questions.
Save My Fat partners with L2 Bio for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review is required before publication. Please consult your physician or attorney before making any decisions about banking or signing a consent form.
